APA (7th ed.) Citation

Jadoon, K. A., Ratcliffe, S. H., Barrett, D. A., Thomas, E. L., Stott, C., Bell, J. D., . . . Tan, G. D. (2016). Efficacy and safety of Cannabidiol and Tetrahydrocannabivarin on glycemic and lipid parameters in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel group pilot study. American Diabetes Association.

Chicago Style (17th ed.) Citation

Jadoon, Khalid A., Stuart H. Ratcliffe, David A. Barrett, E. Louise Thomas, Colin Stott, Jimmy D. Bell, Saoirse O'Sullivan, and Garry D. Tan. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients with Type 2 Diabetes: A Randomized, Double-blind, Placebo-controlled, Parallel Group Pilot Study. American Diabetes Association, 2016.

MLA (9th ed.) Citation

Jadoon, Khalid A., et al. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients with Type 2 Diabetes: A Randomized, Double-blind, Placebo-controlled, Parallel Group Pilot Study. American Diabetes Association, 2016.